ClinicalTrials.govpublic full text
Neoadjuvant Immunotherapy and Chemotherapy Followed by Surgery in Unresectable Stage Ⅲ NSCLC
non small cell lung cancer, unresectable, stage ⅲ nsclc, neoadjuvant, chemoimmunotherapy, camerlizumab, pd-1, sugery, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846201
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.